Viewing Study NCT01266603


Ignite Creation Date: 2025-12-24 @ 7:25 PM
Ignite Modification Date: 2026-03-04 @ 10:12 PM
Study NCT ID: NCT01266603
Status: COMPLETED
Last Update Posted: 2020-02-19
First Post: 2010-12-20
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: High-Dose Interleukin-2 (HDIL-2), Combined With recMAGE-A3 + AS15 ASCI
Sponsor:
Organization: